Drug Shortage Report for PMS-FLUTICASONE HFA

Last updated on 2022-12-01 History
Report ID 169268
Drug Identification Number 02503123
Brand name PMS-FLUTICASONE HFA
Common or Proper name FLUTICASONE HFA
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) FLUTICASONE PROPIONATE
Strength(s) 125MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration ORAL INHALATION
Packaging size 120
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-09-26
Estimated end date 2022-12-07
Actual end date 2022-11-22
Shortage status Resolved
Updated date 2022-12-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-12-01 French Compare
v11 2022-12-01 English Compare
v10 2022-10-28 French Compare
v9 2022-10-28 English Compare
v8 2022-09-27 English Compare
v7 2022-09-26 French Compare
v6 2022-09-26 English Compare
v5 2022-09-20 French Compare
v4 2022-09-20 English Compare
v3 2022-09-20 English Compare
v2 2022-09-15 French Compare
v1 2022-09-15 English Compare

Showing 1 to 12 of 12